Reference Listed Drug Selection
Reference Listed Drug Selection is the regulatory decision-making process in bioequivalence regulation whereby a competent authority designates a specific previously approved drug product as the reference listed drug that serves as the legal and scientific benchmark for establishing pharmaceutical equivalence and bioequivalence of proposed generic products.
3
Publications
50
Citations
19
Authors
14
Institutions
Publications per year
2017–2026
1
Parents
Children
Biopharmaceutics Classification System ApplicationsHatch-waxman Act ApplicationsInhalation Product Reference SelectionInternational Reference Product HarmonizationModified-release Product Reference SelectionMulti-source Reference Product ComparisonNarrow Therapeutic Index Drug SelectionParenteral Reference Product SelectionPharmaceutical Equivalence AssessmentPharmacokinetic Equivalence Criteria
3
The generics in transplantation and the rules on their use.
Marwan Masri · PubMed · 2003 · 12 citations
1–3 of 3
19
1
h-index
Institute for Health Metrics and Evaluation, United States
1 publications · 27 citations
1
h-index
1
h-index
1
h-index
1
h-index
1–5 of 19
14
Georg Simon Ohm University of Applied Sciences Nuremberg
Nuremberg, Germany
1 h-index
1 publications
27 citations
Universidade de Sorocaba
Sorocaba, Brazil
1 h-index
3 publications
33 citations

Eötvös Loránd University
Budapest, Hungary
1 h-index
2 publications
54 citations
University of Washington
Seattle, United States
1 h-index
1 publications
27 citations
Syreon Research Institute (Hungary)
Budapest, Hungary
1 h-index
3 publications
81 citations
University Medical Center Rizk Hospital
Beirut, Lebanon
1 h-index
1 publications
12 citations

McMaster University
Hamilton, Canada
1 h-index
1 publications
11 citations

Comenius University Bratislava
Bratislava, Slovakia
1 h-index
1 publications
27 citations
1–8 of 14
1 publications · 27 citations
1
h-index
1 publications · 11 citations
1
h-index
Repository · 1 publications · 12 citations
1
h-index
1–3